StockStory99d agoneutral
Vertex Pharmaceuticals (VRTX) Q1 Earnings: What To ExpectBiotech company Vertex Pharmaceuticals (NASDAQ:VRTX) will be reporting results this Monday after the bell. Here’s what investors should know.
News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
325last 24h
2344last 7d
424● bullish (7d)
220● bearish (7d)
202publishers
The Wall Street Journal105d agoneutral
There’s a Revolution in Cancer. But Can Big Pharma Afford It?Revolution Medicines’ stock has surged on the promise of a pancreatic-cancer drug. With any deal to buy the firm looking unlikely, investors should be prepared for the long haul.